Skip to content
Gold Mining News – Lifestyle
Home
Sample Page
Author:
Newron Pharmaceuticals SpA
Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
September 2, 2026